Project Number 2R44AI104034-05A1 Agency/Funding Organization NIAID Funding Year 2018 View Full Project Details for Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator RASCHKE, WILLIAM C Principal Investigator First Name WILLIAM C Principal Investigator Last Name RASCHKE Awardee Organization VIROGENICS, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-17-302: PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR [R43/R44]) FY Overall Cost $977,956 Funding Organization Agency/Funding Organization NIAID Funding Organization Country United States Program Official MINNICOZZI, MICHAEL
